Pharming this year among worst stocks in the Netherlands

Because of this years' huge loss of 30 percent the stock is one of the worst shares of the Netherlands. Since the start of this year, the average Dutch stock rose year approximately 13 percent in value. Over the past 3 months the stock price increased (+37 percent).

Returns Pharming versus Dutch stocks

Buy & hold Returns stock Pharming several periods, excluding dividend returns

Investors who invested in 2007 in the company's share now have a massive loss of 89 percent. Since 2012 the stock has a price gain of 441 percent. over the past 90 days the stock made a loss of 37 percent.

For this year Pharming 's revenue will be around 136,92 million euros. This is according to the average of the analysts' estimates. This is quite more than 2017's revenue of 89,62 million euros.

Historical revenues and results Pharming plus estimates 2018

The analysts expect for 2018 a net profit of 18 million euros. According to most of the analysts the company will have a profit per share for this book year of 2 cent. So the price/earnings-ratio equals 40.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a poor 0,5 percent.

Recent target prices around 2 euros

The latest 3 recommendations for the biotech company were provided by Stifel, Beleggers Belangen and Beursexpres.

Pharming 's market capitalization is around 362,19 million euros. The Pharming stock was the past 12 months quite unstable. Since last November the stock is 36 percent lower. This year the stock price moved between 1 and 2 euro. Since 2008 the stock price is almost 89 percent lower.

Historical stock prices Pharming

At 13.27 the stock trades 1,51 percent lower at 0,8 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.